Acceptance and commitment therapy delivered via a mobile phone messaging robot to decrease postoperative opioid use in patients with orthopedic trauma: Randomized controlled trial by Anthony, Chris A et al.
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
2020 
Acceptance and commitment therapy delivered via a mobile 
phone messaging robot to decrease postoperative opioid use in 
patients with orthopedic trauma: Randomized controlled trial 
Chris A Anthony 
Edward Octavio Rojas 
Valerie Keffala 
Natalie Ann Glass 
Apurva S Shah 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs 
Authors 
Chris A Anthony, Edward Octavio Rojas, Valerie Keffala, Natalie Ann Glass, Apurva S Shah, Benjamin J 
Miller, Matthew Hogue, Michael C Willey, Matthew Karam, and John Lawrence Marsh 
Original Paper
Acceptance and Commitment Therapy Delivered via a Mobile
Phone Messaging Robot to Decrease Postoperative Opioid Use
in Patients With Orthopedic Trauma: Randomized Controlled Trial
Chris A Anthony1,2, MD; Edward Octavio Rojas3, MD; Valerie Keffala3, PhD; Natalie Ann Glass3, PhD, MHCDS;
Apurva S Shah4, MD, MBA; Benjamin J Miller3, MD, MS; Matthew Hogue3, MD; Michael C Willey3, MD; Matthew
Karam3, MD; John Lawrence Marsh3, MD
1Department of Orthopaedics, University of Pennsylvania, Philadelphia, PA, United States
2Department of Orthopedic Surgery, Washington University School of Medicine, St Louis, MO, United States
3Department of Orthopaedics and Rehabilitation, University of Iowa Hospitals and Clinics, Iowa City, IA, United States
4Children’s Hospital of Philadelphia Main Campus Division of Orthopaedics, Philadelphia, PA, United States
Corresponding Author:
Edward Octavio Rojas, MD
Department of Orthopaedics and Rehabilitation
University of Iowa Hospitals and Clinics
200 Hawkins Drive
Iowa City, IA, 52242
United States
Phone: 1 319 356 8690
Email: edward-rojas@uiowa.edu
Abstract
Background: Acceptance and commitment therapy (ACT) is a pragmatic approach to help individuals decrease avoidable pain.
Objective: This study aims to evaluate the effects of ACT delivered via an automated mobile messaging robot on postoperative
opioid use and patient-reported outcomes (PROs) in patients with orthopedic trauma who underwent operative intervention for
their injuries.
Methods: Adult patients presenting to a level 1 trauma center who underwent operative fixation of a traumatic upper or lower
extremity fracture and who used mobile phone text messaging were eligible for the study. Patients were randomized in a 1:1 ratio
to either the intervention group, who received twice-daily mobile phone messages communicating an ACT-based intervention
for the first 2 weeks after surgery, or the control group, who received no messages. Baseline PROs were completed. Two weeks
after the operative intervention, follow-up was performed in the form of an opioid medication pill count and postoperative
administration of PROs. The mean number of opioid tablets used by patients was calculated and compared between groups. The
mean PRO scores were also compared between the groups.
Results: A total of 82 subjects were enrolled in the study. Of the 82 participants, 76 (38 ACT and 38 controls) completed the
study. No differences between groups in demographic factors were identified. The intervention group used an average of 26.1
(SD 21.4) opioid tablets, whereas the control group used 41.1 (SD 22.0) tablets, resulting in 36.5% ([41.1-26.1]/41.1) less tablets
used by subjects receiving the mobile phone–based ACT intervention (P=.004). The intervention group subjects reported a lower
postoperative Patient-Reported Outcome Measure Information System Pain Intensity score (mean 45.9, SD 7.2) than control
group subjects (mean 49.7, SD 8.8; P=.04).
Conclusions: In this study, the delivery of an ACT-based intervention via an automated mobile messaging robot in the acute
postoperative period decreased opioid use in selected patients with orthopedic trauma. Participants receiving the ACT-based
intervention also reported lower pain intensity after 2 weeks, although this may not represent a clinically important difference.
Trial Registration: ClinicalTrials.gov NCT03991546; https://clinicaltrials.gov/ct2/show/NCT03991546
(J Med Internet Res 2020;22(7):e17750) doi: 10.2196/17750
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Introduction
Opioid Medication Issues
Public health concerns regarding opioid medications persist,
and health care systems are currently seeking solutions to the
ongoing epidemic [1]. In 2017, the rate of drug overdose deaths
involving opioids in the United States increased by 12%, totaling
47,600 cases, and prescription opioid medications accounted
for over 17,000 of these [2]. Even small amounts of additional
daily opioid utilization (10 morphine milliequivalents [MME])
by patients can lead to an increased risk of long-term misuse
[3]. In addition, every week of continued opioid utilization
represents an increased risk of eventual misuse by patients [3].
Previous studies have found that orthopedic trauma patients use
a decreasing amount of opioid medication in the first 2
postoperative weeks, with 6-15 days being the optimal opioid
use period [4,5]. In line with these findings, previous studies
have used a 2-week postoperative period to assess opioid
medication consumption in surgical patients [4].
Patient-Reported Outcomes
Patient-reported outcomes (PROs) allow patients to quantify
aspects of their orthopedic condition in a standardized fashion
[6,7]. These are important tools for determining the efficacy of
health care treatments and assessment of clinical research and
can be used in determining compensation for health care services
provided [6-8]. The National Institutes of Health developed the
Patient-Reported Outcome Measure Information System
(PROMIS) tools to advance PROs by creating question banks
that could be used for many major health issues [9]. The
PROMIS Pain Intensity 1A Short form, PROMIS Pain Intensity
3A Short form, PROMIS Pain Interference 8A Short form, and
PROMIS Emotional Distress-Anxiety 8A Short form all employ
a fixed low number of questions that are highly reliable when
compared with their respective domain’s full item bank, making
them excellent tools for both patients and clinicians [9,10].
Acceptance and Commitment Therapy
Acceptance and commitment therapy (ACT) is a cognitive
contextual behavioral therapy that employs a pragmatic approach
to help individuals decrease pain and live according to
self-identified personal values [11,12]. The goal of ACT is to
augment an individual’s psychological flexibility, thus
improving their life according to 6 core cognitive processes:
acceptance, defusion, contact with the present moment,
self-as-context, values, and committed action (Table 1) [11].
Employing these cognitive processes to increase psychological
flexibility allows people to choose their actions based on what
they value most, resulting in decreased avoidance behaviors
and negative cognitive associations [11]. ACT has proven to
be effective across multiple studies and patient populations in
the treatment of pain [13]. Several studies report a high value
for ACT in the management of chronic pain when compared
with standard pharmacological treatment alone [13-16].
Moreover, earlier cessation of pain and opioid utilization in
at-risk orthopedic surgery patients receiving office-based ACT
interventions has also been reported [17]. However, traditional
ACT interventions require a clinic-based, interdisciplinary team
approach, which is not always feasible for both patients and
health care systems [17,18].
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Table 1. Acceptance and commitment therapy core principles with associated messages.
Example mobile phone messageCore principle
Stop for a moment and remember the 3 values you identified earlier today. Remind yourself how important these values
are in your life. As your day comes to an end, remember that YOU are in control of the thoughts that exist in your mind.
We encourage you to spend time thinking about your 3 core values identified earlier today.
Values: know what matters
most
Feelings of pain and feelings about your experience of pain are normal after surgery. Acknowledge and accept these
feelings as part of the recovery process. Remember how you feel now is temporary and your healing process will con-
tinue. Call to mind pleasant feelings or thoughts that you experienced today.
Acceptance: setting expecta-
tion that pain is a part of
surgery
Awareness of the present moment and your breathing may change with pain-related emotions or thoughts. Remember
you can always count on your breathing to bring you back to the present moment and help you move through your
current experience of pain.
Present moment awareness:
mindfulness and awareness
for our thoughts in the
present moment
We cannot change that a feeling or thought may arise, but we can choose how we respond to our feelings and thoughts.
Remember that dwelling on pain, discouraging feelings, and thoughts after surgery are NOT consistent with your life
goals and values. Observe things that try to move you away from your values and only act on things that are compatible
with who you want to be and what matters to you.
Self-as-context: awareness
of what is being observed
and noticed by ourselves
Healing after surgery requires you to act. We previously discussed your life goals, meaning, and purpose. Take action
today and move closer toward what you want in life. Recognize that pain may be present but make the choice that it
will not impede your progress toward what you really want in life. Be present in the moment and ensure your actions
remain true to what you want most. All actions you make no matter how small, are an important steppingstone on your
road to recovery.
Committed action: doing
what it takes to live accord-
ing to our values
If you ever feel pain after surgery know that the feeling is real but what it actually represents is not what you might
think. Our mind is capable of making us feel pain, even though there is no damage going on in our body. Pause, become
more aware in the moment and chose a skillful response that will help you move toward your overall goals and values.
Defusion: watch your think-
ing and interact with
thoughts in a way consistent
with your values
Mobile Phone Messaging Communication
Evolving communication methods, such as automated mobile
phone messaging [4,19-21], for health care purposes are
increasingly important, as patients prefer these communication
methods for delivering and receiving medical information [22].
Software-driven, automated mobile phone messaging robots
(also called chatbots or conversational agents) are low-cost tools
that can deliver predefined text-based information and receive
incoming responses with high reliability when patients either
prefer it or it is necessary to communicate at distance [19,23].
This technology demonstrates high efficacy as part of the
treatment of conditions ranging from hypertension to substance
abuse [24-26], and it has also proved effective in increasing
perioperative communication after hip and knee arthroplasty
[27] and collecting pain and opioid medication data from
patients following orthopedic trauma and hand procedures
[4,19]. In addition, automated mobile phone messaging robots
have been validated in the collection of PROs in patients
undergoing orthopedic hand [20] and hip preservation
procedures [23]. Although mobile phone messaging robots
(Chat bots) provide the benefit of communicating with patients
at distance with no need for human intervention, they do
introduce delivery of health care that lacks human interaction
with unknown effects [28].
Health care teams caring for patients with traumatic orthopedic
injuries have traditionally used opioid medication in the
postoperative setting, and these patients are at risk for prolonged
opioid utilization in the postoperative period. We theorized that
the combination of ACT delivered via automated mobile phone
messaging may help to decrease pain and opioid utilization in
the acute postoperative setting. The aim of this prospective
randomized controlled trial was to evaluate the effectiveness of
ACT delivered via an automated mobile messaging robot on
(1) decreasing early postoperative opioid utilization and (2)
pain-related PROs in the first 2 weeks following surgery for
acute traumatic orthopedic injuries.
Methods
Study Approval
This randomized controlled trial was registered with
ClinicalTrials.gov (NCT03991546) and reporting is consistent
with the Consolidated Standards of Reporting Trials guidelines
(Multimedia Appendix 1) [29]. The study was performed at a
single center university hospital in Iowa City, Iowa, United
States. Ethical approval of this study was provided by the
University of Iowa institutional review board, and the study
was determined to be Health Insurance Portability and
Accountability Act compliant.
Recruitment and Randomization
Adults presenting to a university hospital level 1 trauma center
indicated for operative fixation of a traumatic upper or lower
fracture were considered for the study (Table 2). The exclusion
criteria are listed in Textbox 1. Eligible patients were
approached before surgery by a research assistant in a private
room. Individuals not excluded by screening questions and
interested in participating underwent the informed consent
process (Textbox 1). During consent, all subjects were informed
of the outcomes of interests, different study arms, and that no
changes would be made to their care in terms of postoperative
medication, regardless of study participation.
Participants were randomized to either the control or
intervention group using a standard web-based random number
generator with a range set from 1 to 10 and a 1:1 ratio by a
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research assistant. Owing to the nature of this study, subjects
and the enrolling research assistant were not blinded to the
participant’s study group following randomization.
At the time of consent, subjects were required to complete paper
forms comprising a basic demographics questionnaire and
baseline PROs consisting of the PROMIS Pain Intensity 1A
Short form, PROMIS Pain Intensity 3A Short form, PROMIS
Pain Interference 8A Short form, and PROMIS Emotional
Distress-Anxiety 8A Short form (Multimedia Appendix 2).
Following completion of all PROs, participants were randomized
to their study group. Subjects who received an odd number from
the 1 to 10 range set on the random number generator were
placed in the intervention group, whereas subjects given an even
number were placed in the control group.
Table 2. Injury by final study group (N=76).


















aPolytrauma was defined as a patient with a fracture to more than one upper or lower extremity.
Textbox 1. Exclusion criteria.
Screening questions
• No personal mobile phone with text messaging capabilities
• Poor familiarity reading or sending mobile messages
Patient factors
• Open fracture
• Infection at the fracture site
• Prior fracture temporization with an external fixator
• Revision surgery for nonunion or hardware failure
• Bilateral upper extremity injuries impeding their ability to use a mobile phone
• Fractures of the distal hand or distal foot only
• Admission to an intensive care unit
• Current cancer diagnosis or dementia
• Inpatient for more than 7 days of the 2-week study period
• Discharged without an opioid pain medication prescription
• Initial plan for operative fixation changed to treatment with joint arthroplasty
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Study Interventions
The intervention group received twice-daily, text-based mobile
messages communicating an ACT-based intervention for the
first 2 weeks following surgery (Multimedia Appendix 3).
Control group subjects did not receive the ACT intervention or
any other form of mobile message communication. The mobile
messaging ACT protocol consisted of twice per day mobile
messages, morning and evening, starting on postoperative day
(POD) 1 and ending on POD 14. These mobile phone messages
provided participants with an ACT-based intervention that was
developed in collaboration with a pain psychologist (VK)
specializing in ACT for chronic pain. These messages used all
the principles presented in Table 1 with the objective of helping
recipients understand and develop better coping skills in relation
to their postoperative pain. An example message from day 1 is
as follows:
Maintaining focus on what you value most in life is
sometimes difficult after surgery. Do not let the
momentary discomforts due to surgery take away
from what you want most in life. Pick 3 things that
matter most to you in life. Remind yourself of these 3
things you value most during your recovery process.
Outside of the mobile messaging intervention, both groups
received the same standard postoperative care, health care team
communications, and instructions for completing the study
follow-up.
A chart review was performed to collect demographic
information such as subject age, comorbid conditions, and
preoperative outpatient opioid medication prescriptions for
treatment of their current traumatic orthopedic injury. All
subjects, regardless of group, were seen by a research team
member after surgery to review which of their discharge
medications was the medication of interest for the study and to
confirm that the intervention group subjects received their first
mobile phone ACT message. Participants in both groups were
instructed to have their opioid medication bottle available at
follow-up to confirm their opioid tablet consumption. Owing
to the changes in health care teams, staff preferences, and
allergies, the opioid pain medications administered at discharge
were not standardized between study groups. Following
discharge on POD 14, subjects were contacted by phone or seen
in the clinic by the research team for follow-up. At this time,
the subjects’ opioid pain medication consumption was assessed,
and they completed a second set of PROs.
Outcome Measures
The primary outcome of this study was the amount of opioid
pain medication consumed by subjects, and the secondary
outcomes analyzed were net changes from baseline PRO scores
at the 2-week follow-up.
The method that participants employed to report their opioid
medication consumption and how PROs were captured during
follow-up were recorded (Table 3). Subjects using their pill
bottle to confirm the remaining number of opioid pain
medication tablets from their discharge prescription on POD
14 were denoted as reporting a pill count. Cases where subjects
or their care facility kept a log of tablet consumption were
classified as reporting a daily log. Subjects reporting the number
of tablets they used without the use of a log or pill count were
designated as providing an estimate. The percentage of opioid
pain medication used, total MME, and percentage of available
MME consumed were calculated. The mean number of opioid
pain medication tablets and MME used by the subjects were
compared between groups. The raw scores for PROs were
converted to corresponding t-scores using the appropriate
PROMIS scoring manual [30]. The changes in PROs from
baseline to POD 14 were also calculated by subtracting POD
14 scores from baseline scores, as higher t-scores signify a
poorer outcome; thus, lower scores on POD 14 indicate an
improvement from baseline PROs. The mean PRO scores and
changes were compared between the groups.
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Table 3. Comparison of subject demographics by enrolled study group.
P valueControl group (n=40)Acceptance and commitment therapy group (n=42)Subject characteristic
.4148.7 (14.6)45.5 (15.9)Age (years), mean (SD)




N/Aa2 (5)4 (10)Subjects removed or lost to follow-up, n (%)
.206.2 (2.6)5.4 (2.9)Preoperative PROMISb Pain Intensity 1A Score,
mean (SD)
.2357.1 (8.2)54.9 (7.3)Preoperative PROMIS Pain Intensity 3A Score, mean
(SD)
.3066.1 (8.4)63.6 (11.4)Mean Preoperative PROMIS Pain Interference 8A
Score, mean (SD)
.9956.5 (9.2)56.5 (11.4)Mean Preoperative PROMIS Emotional Distress-
Anxiety 8A Score, mean (SD)
.263 (1-50)4 (1-33)Days between injury and surgery, mean (range)
.68Dispositionc, n (%)
34 (90)36 (95)Home
4 (10)2 (5)Skilled nursing facility or acute rehabilitation
.86Ethnicity/race, n (%)
35 (88)37 (88)White
4 (10)4 (10)African American
0 (0)1 (2)Asian
1 (2)0 (0)Hispanic
.1717 (43)23 (55)Preoperative outpatient opioid prescription, n (%)
.149 (23)15 (36)Current psychiatric diagnosis, n (%)
.103 (8)8 (19)History/current substance abuse diagnosis, n (%)
.157 (18)2 (5)Diabetes diagnosis, n (%)
.579 (23)7 (17)Current smoker, n (%)
>.992 (5)1 (2)Current lumbago diagnosis, n (%)
.598 (20)10 (24)History of/current chronic pain diagnosis, n (%)
.6261.6 (22.0)58.8 (27.3)Number of opioid tablets prescribedc, mean (SD)
.47Opioid utilization reporting methodc, n (%)
30 (79)34 (90)Pill count
6 (16)3 (8)Daily log
2 (5)1 (2)Estimate
>.9934 (90)34 (90)Patients filling only one postoperative opioid prescrip-
tionc, n (%)
aN/A: not applicable.
bPROMIS: Patient-Reported Outcome Measures Information System.
cData calculated using final study population only (n=38).
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Statistical Analysis
Participant characteristics were described using mean (SD) or
median (minimum to maximum) for continuous variables and
frequencies (percentages) for categorical variables. Visual
review of histograms and the results of the Shapiro-Wilk test
of continuous variables revealed that only age and BMI were
not normally distributed. Between-group differences were
evaluated using t tests or Wilcoxon rank-sum tests (age and
BMI) for continuous variables and chi-square or exact tests for
categorical variables, as appropriate.
To evaluate whether the intervention versus control group had
a lower opioid use on average, we determined the number of
tablets and MME taken in each group and compared means
using t tests. Using a previous study of opioid medication usage
in orthopedic trauma patients [4], the sample size estimated to
observe a 30% decrease in opioid utilization among 2 groups
required a total of 74 subjects to achieve 80% power at an alpha
of .05. The percent decrease is calculated using the formula
. A separate power analysis was calculated
for the PRO portion of the study, and it was determined that a
total of 36 subjects would provide 80% power to detect a
10-point difference (1 standard deviation) in t-scores for the
PROMIS instruments at an alpha level of .05. Statistical analyses




A total of 125 individuals were approached regarding the study
over the 5-month enrollment period between February 2019
and June 2019. Of the 125 individuals, 2 patients were excluded
at this time, as they were non–English-speaking, and an
additional 24 patients were excluded because they did not use
mobile phone messaging or did not have a personal mobile
phone. This resulted in a total of 99 eligible people who were
presented the study, 17 of whom declined participation (Figure
1). Overall, 82 subjects were enrolled, and 6 dropped from the
study after providing consent because of various issues: one
patient lost to follow-up, one patient withdrew at follow-up,
one patient had incomplete follow-up, one patient’s operative
plan changed to arthroplasty, and 2 subjects remained inpatient
for over 7 days of the study period (Figure 1). This resulted in
a final population of 76 subjects (38 per study group). The
enrollment period concluded once a powered sample for the
primary aim was obtained. A breakdown of the subjects enrolled,
reasons for excluding subjects, and subjects removed from the
study after consent are presented in Figure 1. Participant
demographics for the intervention and control groups are
presented in Table 3. The analyses of all collected demographic
factors showed no differences between the intervention and
control groups in all factors such as subject age (P=.42), current
psychiatric diagnosis (including depression, anxiety, bipolar
type 1, obsessive-compulsive disorder, posttraumatic stress
disorder, panic disorder, and attention-deficit disorder; P=.14),
or substance abuse history (P=.10; Table 3). Furthermore, no
differences between groups were found for injury type,
disposition following discharge, method for reporting opioid
medication consumption, preoperative opioid medication
prescriptions, or preoperative PROs (Table 3).
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Figure 1. Consolidated Standards of Reporting Trials flowchart detailing the selection of eligible patients for study enrollment and their status through
study completion. ACT: acceptance and commitment therapy.
Opioid Pain Medication Use
No differences between groups were observed in the amount
of opioid medication tablets or MME prescribed at discharge
(tablets for the ACT group: mean 58.8, SD 27.3 vs tablets for
the control group: mean 61.6, SD 22.0). A further breakdown
of the medications prescribed to subjects within the study period
is presented in Table 4. The mean opioid tablet use for subjects
in the ACT-based intervention group was 26.1 (SD 21.4) tablets,
whereas the control group used a mean of 41.1 (SD 22.0) tablets,
resulting in 36.5% less tablets used by subjects receiving the
ACT-based intervention (P=.004; Table 5). Similarly, subjects
in the intervention group consumed a mean of 199.9 (SD 163.2)
MME, on average, whereas the control group subjects consumed
a mean of 307.0 (SD 166.0) MME, indicating 34.9% less MME
used by subjects in the intervention group (P=.006; Table 5).
Table 4. Frequency of outpatient opioid pain medications prescribed by enrolled study group (N=82).
FrequencyMorphine milliequivalents per tabletMedication






4346N/AaTotal opioid prescriptions provided
aN/A: not applicable.
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Table 5. Opioid pain medication utilization by group during the 2-week study period.















































aACT: acceptance and commitment therapy.
bCalculated by the formula .
Patient-Reported Outcomes
PROMIS instrument t-score values for both ACT and control
group subjects are presented in Table 6. At 2-week follow-up,
the intervention group subjects reported lower postoperative
PROMIS Pain Intensity 3A (mean 45.9, SD 7.2) and Pain
Interference 8A (mean 56.6, SD 9.4) scores compared with the
control group’s postoperative Pain Intensity 3A (mean 49.7,
SD 8.8; P=.04) and Pain Interference 8A scores (mean 60.6,
SD 8.2; P=.05; Table 6). No differences were observed between
groups at 2-week follow-up in the PROMIS Pain Intensity 1A
or PROMIS Emotional Distress-Anxiety 8A forms (Table 6).
Table 6. Mean Patient-Reported Outcome Measures Information System score and change within the 2-week study period by study group.






































































































aPROMIS: Patient-Reported Outcome Measures Information System.
bACT: acceptance and commitment therapy.
cScores presented are raw numerical scores, as no t-score conversion is available for the selected instrument.
Discussion
Principal Findings
This randomized trial delivered an ACT-based intervention via
an automated mobile messaging robot to postoperative
orthopedic patients. The subjects who received the ACT-based
mobile phone intervention used a lower number of opioid tablets
and consumed less MME in the first 2 weeks after their injury.
We also found that the intervention group reported less pain
intensity and pain interference at the 2-week follow-up. These
data demonstrate that ACT-based automated mobile messaging
protocols may be effective in reducing the amount of opioid
medication used and may positively affect postoperative PROs
in patients undergoing operative fixation of their acute fractures.
Effects on Opioid Use
Improved mood symptoms, less pain interference, and faster
cessation of opioid pain medication are some of the recognized
benefits of using ACT in clinic-based, interdisciplinary
approaches to pain management after surgery [17,18]. Previous
investigations have used automated mobile phone messaging
robots to deliver PROs [20,23], improve communication with
patients [27,31], deliver postoperative orthopedic care [32], and
inquire about pain and opioid utilization [4,19,33]. In this study,
we used ACT and a mobile phone messaging robot to assess
whether these tools in combination could decrease opioid
utilization and improve individuals’ perception of their early
recovery from injury. Prior work has demonstrated a quicker
time to opioid cessation and a decrease in postoperative opioid
utilization (14% less in the ACT group) when used in office
ACT-based treatments [17,18]. Subjects receiving the ACT
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intervention via automated mobile phone messages reported
over 36% less opioid tablets and more than 34% less MME
consumed than corresponding control subjects who did not
receive ACT. Our findings suggest that software-based
communication using ACT through a mobile phone has the
potential to have a large impact on the utilization of
postoperative pain medication by patients in the first weeks
after surgery for fractures. Further study is required to determine
if these effects are long lasting and to determine which injuries
and patients receive the greatest benefit. In addition, future
investigations and trials should consider the effect of software
delivery of ACT and other behavioral therapies on different
cohorts of patients.
Effects on PROs
PROs, such as PROMIS, allow patients to quantify aspects of
their orthopedic condition in a standardized fashion [6,7]. These
are important tools for determining the efficacy of health care
treatments and assessment of clinical research and can be used
in determining compensation for health care services provided
[6-8]. The National Institutes of Health developed the PROMIS
tools to advance PROs by creating question banks that could
be used for many major health issues [9]. We found that despite
less utilization of opioids, subjects in the ACT-based
intervention group reported less pain intensity and pain
interference at 2 weeks. This most likely does not represent a
clinically important difference based on the SD methodology
used in prior works with PROMIS tools (Table 6), but it at least
suggests that the intervention group did not experience greater
pain [34]. There were no other differences between study groups
in the other domains at the 2-week follow-up. Previous studies
have reported that patients who consume more opioid
medication report higher pain at both short- and long-term time
points, which is reflected in our findings for both PROMIS pain
intensity 3A and the employed pain interference measure
[35,36]. Future research efforts may benefit from employing
alternative PRO measures to identify the effects of ACT-based
interventions, including assessment of psychologic flexibility.
Future research may also consider possible modifications of
our study protocol to include a longer intervention period and
more than one follow-up data point. Future work may also
consider designing an ACT-based tool that is more focused on
demonstrating an effect on PROs.
Limitations
Several limitations were present in this study. First, we were
limited to a single level 1 trauma center, which may affect the
reproducibility of our results across other health care settings.
Next, the exclusion criteria for this study were extensive, and
thus, the results may not be generalizable to the entire scope of
orthopedic trauma patients. We attempted to include a diverse
set of injuries and yet excluded patients with a high likelihood
of confounding problems from open fractures or prolonged
initial hospitalization. Future studies assessing the effects of
ACT-based interventions similar to ours should aim for less
restrictive exclusion criteria to apply this intervention to a larger,
more diverse population. The research assistants were not
blinded to the patients’ study group. In addition, patients
understood the outcomes of interest in this study, which could
be susceptible to reporting bias. In addition, participants were
not blinded to their treatment group. The lack of blinding could
potentially introduce response or reporting bias, making this a
potential area of improvement for studies seeking to follow the
present methodology. This could be accomplished through the
implementation of a control messaging protocol. Moreover, a
retrospective chart review was used to obtain several patient
factors, including comorbid conditions and dispensing of
preoperative outpatient opioid medication prescriptions. The
collection of information in this manner relies on accurate
charting and transfer of documents from outside institutions,
which may have been incomplete.
Conclusions
In this study, delivering an ACT-based intervention via an
automated mobile messaging robot in the acute postoperative
period decreased opioid utilization in orthopedic trauma patients
in the first 2 weeks after their injury. Subjects in the ACT-based
intervention group also reported lower pain intensity and pain
interference after 2 weeks, although this likely did not represent
a clinically important difference. Future studies may apply this
intervention in other patient populations to assess its efficacy
on a larger scale and may include assessment of pain and opioid
use in a longer time frame after injury.
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